RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY

H. Nägele,; S. Behrens,; S. Hashagen,; M. Azizi,

doi:10.1515/DMDI.2007.22.2-3.195

Startseite RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY

Artikel

Lizenziert

Nicht lizenziert Erfordert eine Authentifizierung

RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY

H. Nägele, , S. Behrens, , S. Hashagen, und M. Azizi,

Veröffentlicht/Copyright: 1. Juni 2007

Veröffentlicht von

Veröffentlichen auch Sie bei De Gruyter Brill

Manuskript einreichen Informationen für Autor*innen

Aus der Zeitschrift Drug Metabolism and Drug Interactions Band 22 Heft 2-3

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Nägele,, H., Behrens,, S., Hashagen,, S. and Azizi,, M.. "RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY" Drug Metabolism and Drug Interactions, vol. 22, no. 2-3, pp. 195-200. https://doi.org/10.1515/DMDI.2007.22.2-3.195

Nägele,, H., Behrens,, S., Hashagen,, S. & Azizi,, M. (). RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY. Drug Metabolism and Drug Interactions, 22(2-3), 195-200. https://doi.org/10.1515/DMDI.2007.22.2-3.195

Nägele,, H., Behrens,, S., Hashagen,, S. and Azizi,, M. () RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY. Drug Metabolism and Drug Interactions, Vol. 22 (Issue 2-3), pp. 195-200. https://doi.org/10.1515/DMDI.2007.22.2-3.195

Nägele,, H., Behrens,, S., Hashagen,, S. and Azizi,, M.. "RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY" Drug Metabolism and Drug Interactions 22, no. 2-3 (): 195-200. https://doi.org/10.1515/DMDI.2007.22.2-3.195

Nägele, H, Behrens, S, Hashagen, S, Azizi, M. RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY. Drug Metabolism and Drug Interactions. ;22(2-3): 195-200. https://doi.org/10.1515/DMDI.2007.22.2-3.195

Kopie

In die Zwischenablage kopiert

BibTeX EndNote RIS

Published Online: 2007-06

Sie haben derzeit keinen Zugang zu diesem Inhalt.

Artikel in diesem Heft

CONTENTS
CHIRALITY AND PHARMACOKINETICS: AN AREA OF NEGLECTED DIMENSIONALITY?
A REVIEW ON THE RELATION BETWEEN THE BRAIN-SERUM CONCENTRATION RATIO OF DRUGS AND THE INFLUENCE OF P-GLYCOPROTEIN
EVALUATION OF THE CHEMOPROTECTIVE EFFECT OF Biophytum sensitivum (L.) DC EXTRACT AGAINST CYCLOPHOSPHAMIDE INDUCED TOXICITY IN SWISS ALBINO MICE
EFFECT OF RIFAMPICIN PRETREATMENT ON THE TRANSPORT ACROSS RAT INTESTINE AND ORAL PHARMACOKINETICS OF ORNIDAZOLE IN HEALTHY HUMAN VOLUNTEERS
BIOAVAILABILITY OF DICLOFENAC SODIUM AFTER PRETREATMENT WITH DIOSMIN IN HEALTHY VOLUNTEERS
EFFECT OF SILYMARIN ON THE ORAL BIOAVAILABILITY OF RANITIDINE IN HEALTHY HUMAN VOLUNTEERS
ISOFLURANE REDUCES THE SYNTHESIS OF SURFACTANT-RELATED PROTEIN A OF ALVEOLAR TYPE II CELLS INJURED BY H2O2
RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY

Zeitschrift durchsuchen In dieser Zeitschrift suchen

https://doi.org/10.1515/DMDI.2007.22.2-3.195

Artikel in diesem Heft

CONTENTS
CHIRALITY AND PHARMACOKINETICS: AN AREA OF NEGLECTED DIMENSIONALITY?
A REVIEW ON THE RELATION BETWEEN THE BRAIN-SERUM CONCENTRATION RATIO OF DRUGS AND THE INFLUENCE OF P-GLYCOPROTEIN
EVALUATION OF THE CHEMOPROTECTIVE EFFECT OF Biophytum sensitivum (L.) DC EXTRACT AGAINST CYCLOPHOSPHAMIDE INDUCED TOXICITY IN SWISS ALBINO MICE
EFFECT OF RIFAMPICIN PRETREATMENT ON THE TRANSPORT ACROSS RAT INTESTINE AND ORAL PHARMACOKINETICS OF ORNIDAZOLE IN HEALTHY HUMAN VOLUNTEERS
BIOAVAILABILITY OF DICLOFENAC SODIUM AFTER PRETREATMENT WITH DIOSMIN IN HEALTHY VOLUNTEERS
EFFECT OF SILYMARIN ON THE ORAL BIOAVAILABILITY OF RANITIDINE IN HEALTHY HUMAN VOLUNTEERS
ISOFLURANE REDUCES THE SYNTHESIS OF SURFACTANT-RELATED PROTEIN A OF ALVEOLAR TYPE II CELLS INJURED BY H2O2
RHABDOMYOLYSIS AFTER ADDITION OF DIGITOXIN TO CHRONIC SIMVASTATIN AND AMIODARONE THERAPY